This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02749/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02749/identifier/pubchem-compound/
n6http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB02749/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB02749/identifier/drugbank/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02749/identifier/chemspider/

Statements

Subject Item
n2:DB02749
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB02749 n12:DB02749
dcterms:title
Pyromellitic Acid
adms:identifier
n9:46506312 n10:PMA n11:6961 n13:6695 n14:DB02749
n3:synthesisReference
Anatoli Onopchenko, Johann G. D. Schulz, "PROCESS FOR PREPARING PYROMELLITIC ACID." U.S. Patent US4016206, issued October, 1962.
n3:IUPAC-Name
n4:271B54A7-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B54AD-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B54AC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B54A9-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B54AA-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B54AB-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B54BC-363D-11E5-9242-09173F13E4C5 n4:271B54A5-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B54A3-363D-11E5-9242-09173F13E4C5 n4:271B54A6-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B54A4-363D-11E5-9242-09173F13E4C5
n3:pKa
n4:271B54BE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B54B3-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B54B4-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B54AE-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B54AF-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B54B1-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B54B0-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B54B2-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
89-05-4
n3:Bioavailability
n4:271B54B8-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B54BA-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B54BB-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B54BD-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B54B7-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B54B6-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B54B9-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B54A8-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B54B5-363D-11E5-9242-09173F13E4C5